Calcineurin inhibitor minimization using sirolimus leads to improved renal function in pediatric heart transplant recipients

Pediatric Transplantation

Volumn 15, Issue 7, 2011, Pages 746-749

  Chinnock, Timothy J ^a   Shankel, Tamara ^b   Deming, Douglas ^c   Cutler, Drew ^b   Sahney, Shobha ^b   Fitts, James ^b   Chinnock, Richard E ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b Department of Pediatrics ^*  (United States)

^c LOMA LINDA UNIVERSITY   (United States)

Author keywords

heart transplant; renal insufficiency; sirolimus

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; CYCLOSPORIN; DILTIAZEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PENTETREOTIDE IN 111; RAPAMYCIN; VERAPAMIL;

ANEMIA; APTHOUS ULCER; ARTICLE; CARDIAC GRAFT REJECTION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EDEMA; GLOMERULUS FILTRATION RATE; GRAFT RECIPIENT; HEART TRANSPLANTATION; HUMAN; INFANT; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MEDICAL RECORD REVIEW; NEUTROPENIA; PRESCHOOL CHILD; PROPHYLAXIS; TREATMENT RESPONSE; TREMOR; ULCER;

CALCINEURIN; CHILD; CYCLOSPORINE; GLOMERULAR FILTRATION RATE; HEART TRANSPLANTATION; HUMANS; HYPERCHOLESTEROLEMIA; IMMUNOSUPPRESSIVE AGENTS; IMMUNOTHERAPY; INFANT; INFANT, NEWBORN; KIDNEY; NEUTROPENIA; RETROSPECTIVE STUDIES; RISK; SIROLIMUS; TIME FACTORS;

EID: 80055003426     PISSN: 13973142     EISSN: 13993046     Source Type: Journal    
DOI: 10.1111/j.1399-3046.2011.01566.x     Document Type: Article

References (15)

1. Weizhong Cai, Lan Hu, Foulkes JG,. Transcription-modulating drugs: Mechanism and selectivity. Curr Opin Biotechnol 1996: 7: 608-615.
2. Sachdeva R, Blaszak RT, Ainley KA, Parker JG, Morrow WR, Frazier EA,. Determinants of renal function if pediatric heart transplant recipients: Long-term follow-up study. J Heart Lung Transplant 2007: 26: 108-113.
3. Kirk R, Edwards LB, Aurora P,. Registry of the International Society for Heart and Lung Transplantation: Twelfth official pediatric heart transplantation report-2009. J Heart Lung Transplant 2009: 28: 993-1006.
4. Gustafsson F, Ross H,. Renal-sparing strategies in cardiac transplantation. Curr Opin Organ Transplant 2009: 14: 566-570.
5. Augustine JJ, Bodziak KA, Hricik DE,. Use of sirolimus in solid organ transplantation. Drugs 2007: 67: 369-391.
6. Kahan BD, Kramer WG,. Median effect analysis of efficacy versus adverse effects of immunosuppressants. Clin Pharmacol Ther 2001: 70: 74-81.
7. Balfour I, Srun SW, Wood EG, Belsha CW, Marshall DL, Ferdman BR,. Early renal benefit of rapamycin combined with reduced calcineurin inhibitor dose in pediatric heart transplantation patients. J Heart Lung Transplant 2006: 25: 518-522.
8. Lobach NE, Pollock-Barziv SM, West LJ, Dipchand AI,. Sirolimus immunosuppression in pediatric heart transplant recipients: A single-center experience. J Heart Lung Transplant 2005: 24: 184-189.
9. Sindhi R,. Sirolimus in pediatric transplant recipients. Transplant Proc 2003: 35: 113S-114S.
10. MacDonald AS,. Rapamycin in combination with cyclosporine or tacrolimus in liver, pancreas, and kidney transplantation. Transplant Proc 2003: 35 (Suppl. 3A): 201S-208S.
11. MacDonald AS,. Management strategies for nephrotoxicity. Transplantation 2000: 69: 5531-5536.
12. Bestetti R, Theodoropoulos TA, Burdmann EA, Filho MA, Cordeiro JA, Villafanha D,. Switch from calcineurin inhibitors to sirolimus-induced renal recovery in heart transplant recipients in the midterm follow-up. Transplantation 2006: 81: 692-696.
13. Kushawa SS, Khalpey Z, Edwards BS, et al., Sirolimus in cardiac transplantation: Use as a primary immunosuppressant in calcineurin inhibitor-induced nephrotoxicity. J Heart Lung Transplant 2005: 24: 2129-2136.
14. Hunt J, Lerman M, Magee MJ, Dewey TM, Herbert M, Mack MJ,. Improvement of renal dysfunction by conversion from calcineurin inhibitors to sirolimus after heart transplantation. J Heart Lung Transplant 2005: 24: 1863-1867.
15. Potter BJ, Gianetti N, Edwardes MD, Cecere R, Cantarovich M,. Calcineurin inhibitor substitution with sirolimus vs. reduced-dose calcineurin inhibitor plus sirolimus is associated with improved renal dysfunction in heart transplant patients. Clin Transplant 2007: 21: 305-308.